CTLA4 and chronic hepatitis B virus infection: These data demonstrated that the high frequency of CTLA4+CD4+CXCR5−FOXP3+ T cells at 12 weeks of therapy predicted unfavorable outcome in chronic hepatitis B and suggested that this population may contribute to HBV persistence.